Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Other Income/Expenses (Net)

$469.50M

Quarterly · Period ending: · USD

BIO logo

BIO Other Income/Expenses (Net)

Latest reported$469.50M
BIO Quarterly Other Income/Expenses (Net) (-$25.40M → $469.50M)
High-resolution chart · PNG

BIO other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-8,350,000
-16,721,000
-2,716,000
6,210,000
-10,787,000
-14,031,000
-28,000,000
-1,000,000
-1,394,000
-1,638,000
200,000
300,000
3,300,000
-700,000
-3,100,000
-300,000
-300,000
-300,000
-4,100,000
0
0
-1,400,000
-1,400,000
-2,200,000
-400,000
-1,900,000
-2,600,000
-2,300,000
-4,300,000
-3,500,000
-2,100,000
-1,600,000
-2,300,000
400,000
-2,100,000
700,000
18,100,000
-3,700,000
-1,000,000
-2,500,000
-2,600,000
-2,500,000
-2,600,000
-1,600,000
-1,500,000
-1,400,000
-400,000
-1,500,000
-1,600,000
-56,300,000
125,800,000
-46,200,000
-49,000,000
-50,500,000
99,000,000
-39,000,000
-38,900,000
-37,500,000
80,700,000
-31,100,000
-31,400,000
-30,000,000
66,400,000
-25,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.